Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Whole Brain Radiation Therapy for Brain Metastases
NCT00389584Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Dec 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of irinotecan in brain metastases (2 arms), sponsored by University of California, Davis. Primary endpoints: Maximum Tolerated Dose, Toxicity and 1 more. Started Dec 2002; status: completed.
02
Drugs
irinotecan
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00389584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389584.